Item | Trial group (n = 69) | Control group (n = 36) | P | |
---|---|---|---|---|
Sex | 0.362 | |||
Male | 50 | 29 | ||
Female | 19 | 7 | ||
Median age (year) | 52 | 51 | 0.437 | |
Type of tumors | 0.638* | |||
NSCLC | 17 | 6 | ||
Gastric cancer | 32 | 18 | ||
Colorectal cancer | 20 | 12 | ||
KPS () | 85.31 ± 6.07 | 86.69 ± 7.81 | 0.334 | |
Clinical stage | 0.630 | |||
III | 11 | 8 | ||
IV | 58 | 28 | ||
NSCLC | III | 5 | 3 | 0.621* |
IV | 12 | 3 | ||
Gastric cancer | III | 4 | 3 | 0.684 |
IV | 28 | 15 | ||
Colorectal cancer | III | 2 | 2 | 0.620* |
IV | 18 | 10 |